450 related articles for article (PubMed ID: 38711100)
1. Small molecule inhibitors targeting m
Feng G; Wu Y; Hu Y; Shuai W; Yang X; Li Y; Ouyang L; Wang G
J Hematol Oncol; 2024 May; 17(1):30. PubMed ID: 38711100
[TBL] [Abstract][Full Text] [Related]
2. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
3. Targeting Epigenetics in Cancer.
Bennett RL; Licht JD
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
[TBL] [Abstract][Full Text] [Related]
4. Targeting the epigenetic regulation of antitumour immunity.
Hogg SJ; Beavis PA; Dawson MA; Johnstone RW
Nat Rev Drug Discov; 2020 Nov; 19(11):776-800. PubMed ID: 32929243
[TBL] [Abstract][Full Text] [Related]
5. Targeting components of epigenome by small molecules.
You JS; Han JH
Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
Liang Z; Kidwell RL; Deng H; Xie Q
Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
[TBL] [Abstract][Full Text] [Related]
7. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
Ma J; Yang D; Ma XX
Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
[TBL] [Abstract][Full Text] [Related]
8. Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors.
Zhang Y; Rong D; Li B; Wang Y
J Med Chem; 2021 Jun; 64(12):7900-7925. PubMed ID: 33599482
[TBL] [Abstract][Full Text] [Related]
9. Targeting RNA N
Li W; Hao Y; Zhang X; Xu S; Pang D
Mol Cancer; 2022 Sep; 21(1):176. PubMed ID: 36071523
[TBL] [Abstract][Full Text] [Related]
10. The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer.
Cheng Y; Wang M; Zhou J; Dong H; Wang S; Xu H
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33808751
[TBL] [Abstract][Full Text] [Related]
11. RNA N
Zhang Z; Zhang C; Luo Y; Zhang G; Wu P; Sun N; He J
Clin Transl Med; 2021 Sep; 11(9):e525. PubMed ID: 34586737
[TBL] [Abstract][Full Text] [Related]
12. m
Huang H; Weng H; Chen J
Cancer Cell; 2020 Mar; 37(3):270-288. PubMed ID: 32183948
[TBL] [Abstract][Full Text] [Related]
13. Small-molecular modulators of cancer-associated epigenetic mechanisms.
Itoh Y; Suzuki T; Miyata N
Mol Biosyst; 2013 May; 9(5):873-96. PubMed ID: 23511667
[TBL] [Abstract][Full Text] [Related]
14. Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer.
Zhang Y; Ling Y; Zhou Y; Shi X; Shen F; Zhou J; Chen Y; Yang F; Gu Y; Wang J
Cancer Control; 2024; 31():10732748241256819. PubMed ID: 38755968
[TBL] [Abstract][Full Text] [Related]
15. N
Quan C; Belaydi O; Hu J; Li H; Yu A; Liu P; Yi Z; Qiu D; Ren W; Ma H; Gong G; Ou Z; Chen M; Sun Y; Chen J; Zu X
Front Immunol; 2021; 12():697026. PubMed ID: 34526985
[TBL] [Abstract][Full Text] [Related]
16. N
Yao W; Han X; Ge M; Chen C; Xiao X; Li H; Hei Z
Cell Death Dis; 2020 Jun; 11(6):478. PubMed ID: 32581252
[TBL] [Abstract][Full Text] [Related]
17. Biological and pharmacological roles of m
Liu Z; Zou H; Dang Q; Xu H; Liu L; Zhang Y; Lv J; Li H; Zhou Z; Han X
Mol Cancer; 2022 Dec; 21(1):220. PubMed ID: 36517820
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
19. The Emerging Roles of RNA m
Lan Q; Liu PY; Bell JL; Wang JY; Hüttelmaier S; Zhang XD; Zhang L; Liu T
Cancer Res; 2021 Jul; 81(13):3431-3440. PubMed ID: 34228629
[TBL] [Abstract][Full Text] [Related]
20. Targeting Legumain As a Novel Therapeutic Strategy in Cancers.
Mai CW; Chung FF; Leong CO
Curr Drug Targets; 2017; 18(11):1259-1268. PubMed ID: 27993111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
